Sreekala Prabhakaran

Sreekala Prabhakaran, M.D.

Clinical Associate Professor

Department: MD-PEDS-PULMONARY
Business Phone: (352) 273-8381
Business Email: sprabhakaran@peds.ufl.edu

About Sreekala Prabhakaran

Dr. Sreekala Prabhakaran has been a faculty in the UF Pediatric department since 2010. She is a Clinical Associate Professor and the Director of the Pediatric Severe Asthma Program at UF Health. Dr. Prabhakaran attended medical school in India, did her pediatric residency at Maimonides Medical Center in New York, and completed both Pulmonary and Sleep fellowships at UF. She is board certified in Pediatric Pulmonary Medicine and Sleep Medicine. During her fellowship in the Pediatric Pulmonary Division, Dr. Prabhakaran was a trainee in the federally funded UF Pediatric Pulmonary Center Interdisciplinary Leadership Training Program, a program on which she now serves as faculty. Dr. Prabhakaran envisioned and implemented the innovative interdisciplinary Severe Asthma Program. This interdisciplinary clinical program includes nursing, nutrition, social work and a new medico-legal partnership in which attorneys from the Southern Legal Counsel attend and assist patients in clinic. The clinic serves over 50 patients with severe asthma and has resulted in decreased hospital and ICU stays and decreased ER visits in this population. She has given several presentations on the topic of pediatric asthma and has a number of publications and a book chapter on this topic. She is interested in global health and has participated in patient care in India, as well as assisting on a medical mission trip to Zambia

Board Certifications

  • Pediatric Pulmonary
    American Board of Pediatrics
  • Sleep Medicine Board
    American Board of Pediatrics

Clinical Profile

Specialties
  • Pediatrics
Subspecialties
  • Pediatric Pulmonary

Publications

2021
Daily adherence variability and psychosocial differences in adolescents with asthma: a pilot study.
Journal of behavioral medicine. [DOI] 10.1007/s10865-021-00247-5. [PMID] 34357514.
2020
Adaptive Mobile Health Intervention for Adolescents with Asthma: Iterative User-Centered Development.
JMIR mHealth and uHealth. 8(5) [DOI] 10.2196/18400. [PMID] 32374273.
2020
Arnold-Chiari malformation: an uncommon etiology for a brief resolved, unexplained event in an infant.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 16(11):1983-1984 [DOI] 10.5664/jcsm.8720. [PMID] 32755536.
2020
Continuous Albuterol With Benzalkonium in Children Hospitalized With Severe Asthma
Pediatrics. 145(4) [DOI] 10.1542/peds.2019-0107. [PMID] 32165556.
2020
Situating household management of children’s asthma in the context of social, economic, and environmental injustice.
The Journal of asthma : official journal of the Association for the Care of Asthma. 1-9 [DOI] 10.1080/02770903.2020.1837159. [PMID] 33107771.
2019
Responsive Asthma Care for Teens (ReACT): development protocol for an adaptive mobile health intervention for adolescents with asthma.
BMJ open. 9(8) [DOI] 10.1136/bmjopen-2019-030029. [PMID] 31434777.
2018
Direct Observed Therapy of Inhaled Corticosteroids for Asthma at School or Daycare.
Pediatric allergy, immunology, and pulmonology. 31(4):226-229 [DOI] 10.1089/ped.2018.0912. [PMID] 30595951.
2017
Benzalkonium Chloride: A Bronchoconstricting Preservative in Continuous Albuterol Nebulizer Solutions.
Pharmacotherapy. 37(5):607-610 [DOI] 10.1002/phar.1929. [PMID] 28349590.
2016
Bioassay of salmeterol in children using methacholine challenge with impulse oscillometry.
Pediatric pulmonology. 51(6):570-5 [DOI] 10.1002/ppul.23345. [PMID] 26575323.
2016
Long-term variability of exhaled nitric oxide measurements.
The journal of allergy and clinical immunology. In practice. 4(1):147-8.e1 [DOI] 10.1016/j.jaip.2015.09.010. [PMID] 26563669.
2014
Glucose stimulates calcium-activated chloride secretion in small intestinal cells.
American journal of physiology. Cell physiology. 306(7):C687-96 [DOI] 10.1152/ajpcell.00174.2013. [PMID] 24477233.
2012
Response to albuterol MDI delivered through an anti-static chamber during nocturnal bronchospasm.
Respiratory care. 57(8):1291-6 [DOI] 10.4187/respcare.01572. [PMID] 22348270.
2011
Methacholine challenge as a clinical bioassay of pulmonary delivery of a long-acting β₂-adrenergic agonist
Pharmacotherapy. [DOI] 10.1592/phco.31.5.449. [PMID] 21923426.
2011
Methacholine challenge as a clinical bioassay of pulmonary delivery of a long-acting β₂-adrenergic agonist.
Pharmacotherapy. 31(5):449-57 [DOI] 10.1592/phco.31.5.449. [PMID] 21923426.
2011
Plastic bronchitis: resolution after heart transplantation.
Pediatric pulmonology. 46(8):824-5 [DOI] 10.1002/ppul.21432. [PMID] 21465672.
2011
Response To Albuterol Delivered Through An Anti-Static Valved Holding Chamber During Nocturnal Bronchospasm
Journal of Allergy and Clinical Immunology. 127(2):AB67-AB67 [DOI] 10.1016/j.jaci.2010.12.278.

Grants

Jan 2021 ACTIVE
Central Nervous System Plasticity in Airway Disease
Role: Co-Investigator
Funding: NATL INST OF HLTH NHLBI
Nov 2020 ACTIVE
BDNF Regulation of Mucin in Cystic Fibrosis
Role: Co-Investigator
Funding: CYSTIC FIBROSIS FOU
Sep 2020 ACTIVE
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
Role: Other
Funding: NATL INST OF HLTH NIAMS
Jul 2020 – Jun 2021
109 Cystic Fibrosis Foundation Care Center and Patient Registry
Role: Co-Investigator
Funding: CYSTIC FIBROSIS FOU
Jun 2020 ACTIVE
AIM2ACT: A Mobile Health Tool to Facilitate Asthma Self-Management during Early Adolescence
Role: Co-Investigator
Funding: NATL INST OF HLTH NHLBI
Jul 2019 – Jun 2020
109 Cystic Fibrosis Foundation Care Center and Patient Registry
Role: Co-Investigator
Funding: CYSTIC FIBROSIS FOU
Oct 2018 ACTIVE
Child Asthma Exacerbation: Role of Caregiver Risk Beliefs
Role: Co-Investigator
Funding: WASHINGTON UNIV SAINT LOUIS via NATL INST OF HLTH NHLBI
Sep 2018 – Aug 2021
ReACT an Adaptive Mobile Health Intervention for Adolescent Asthma
Role: Co-Investigator
Funding: UNIV OF KANSAS via NATL INST OF HLTH NHLBI
Jul 2016 ACTIVE
FLDOH CMS Disease Management Contract – COQWY
Role: Principal Investigator
Funding: FL DEPT OF HLTH CHILDRENS MED SERVS
Mar 2003 – Jan 2021
03031755
Role: Principal Investigator
Funding: UF RESEARCH FOU via MISCELLANEOUS DONORS

Patents

Issued October 2018
Materials and Methods for Treatment of Cystic Fibrosis and For Induction of Ion Secretion
#10,086,007
Published September 2018
Materials and Methods for Treatment of Cystic Fibrosis and For Induction of Ion Secretion
#UF-2019-0000865-A1

Education

Residency – Pediatrics
2005 · Maimonides Medical Center
Bachelor of Medicine, Bachelor of Surgery
1999 · Kottayam University

Teaching Profile

Courses Taught
2018
MDT7400 Elect Top/Pediatrics

Contact Details

Phones:
Business:
(352) 273-8381
Emails: